G. Videtic

发表

Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer

J. M. Michalski, Maria Werner-Wasik, J. D. Bradley, 2014 .

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927).

Joe Y. Chang, Steven E Schild, Chen Hu, 2015, International journal of radiation oncology, biology, physics.

Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)

Anurag K. Singh, P. Iyengar, H. Choy, 2016 .

Stereotactic body radiation therapy for inoperable early stage lung cancer.

Andrea Bezjak, Hak Choy, Jeffrey Bradley, 2010, JAMA.

Treatment of Peripheral Non–Small Cell Lung Carcinoma with Stereotactic Body Radiation Therapy

J. Bradley, G. Videtic, M. Roach, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical Investigation : Thoracic Cancer No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy for Early-Stage Peripheral Non-Small Cell Lung Cancer : An Analysis of RTOG 0236

R. Timmerman, A. Bezjak, J. Bradley, 2022 .

Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.

P. Xia, C. Reddy, T. Djemil, 2014, International journal of radiation oncology, biology, physics.

Lung cancer radiation therapy: Defining optimal evidence-based treatment approaches

G. Videtic, C. Shah, K. Stephans, 2016, Applied Radiation Oncology.

Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.

J. Bradley, C. Robinson, G. Videtic, 2018, Practical radiation oncology.

One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.

Anurag K. Singh, G. Videtic, J. Bogart, 2019, International journal of radiation oncology, biology, physics.

Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.

T. Zhuang, C. Reddy, G. Videtic, 2018, International journal of radiation oncology, biology, physics.

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).

C. Reddy, T. Djemil, C. Robinson, 2009, International journal of radiation oncology, biology, physics.

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes

S. Murthy, L. Rybicki, G. Videtic, 2017, Journal of Gastrointestinal Cancer.

The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.

S. Murthy, L. Rybicki, G. Videtic, 2016, Journal of gastrointestinal oncology.

A Phase II Trial of Induction Epirubicin, Oxaliplatin, and Fluorouracil, Followed by Surgery and Postoperative Concurrent Cisplatin and Fluorouracil Chemoradiotherapy in Patients with Locoregionally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction

T. Rice, S. Murthy, L. Rybicki, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy

P. Xia, T. Zhuang, T. Djemil, 2013, Journal of applied clinical medical physics.

Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.

L. Stitt, E. Yu, G. Videtic, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of the Disease‐Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC

G. Barnett, C. Reddy, M. Vogelbaum, 2018, Clinical lung cancer.

Lung Stereotactic Body Radiation Therapy: Regional Nodal Failure Is Not Predicted by Tumor Size

C. Reddy, G. Videtic, K. Stephans, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.

T. Rice, S. Murthy, T. Mekhail, 2008, International journal of radiation oncology, biology, physics.

SINGLE BRAIN METASTASIS

J. Buatti, J. Bradley, I. Germano, 2012 .

ACR Appropriateness Criteria: single brain metastasis.

M. McDermott, L. Gaspar, I. Germano, 2010, Current problems in cancer.

Five-year survivors of brain metastases: a single-institution report of 32 patients.

S. Toms, G. Barnett, M. Vogelbaum, 2006, International journal of radiation oncology, biology, physics.

Salvage Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Primary Surgical Resection of Non-small-cell Lung Cancer.

C. Reddy, G. Videtic, K. Stephans, 2020, Clinical lung cancer.

Handbook of Treatment Planning in Radiation Oncology

A. Vassil, G. Videtic, N. Woody, 2010 .

Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer

Ashutosh Kumar Singh, Joe Y. Chang, H. Choy, 2019 .

Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)

Ashutosh Kumar Singh, P. Iyengar, H. Choy, 2016 .

A Principal Component of Quality-of-Life Measures Is Associated with Survival: Validation in a Prospective Cohort of Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy

Anurag K. Singh, G. Videtic, J. Bogart, 2021, Cancers.

The Radiation Target in Small Cell Lung

G. Videtic, 2021, Medical Radiology.

The Radiation Target in Small-Cell Lung Cancer

G. Videtic, 2011 .

Primary carcinoid tumors of the lung: a role for radiotherapy.

G. Videtic, H. Mackley, 2006, Oncology.

ACR Appropriateness Criteria® pre-irradiation evaluation and management of brain metastases.

J. Buatti, J. Bradley, S. Lo, 2014, Journal of palliative medicine.

RADIATION THERAPY FOR SMALL-CELL LUNG CANCER

K. Rosenzweig, I. Chetty, L. Kestin, 2012 .

Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment?

L. Stitt, E. Yu, G. Videtic, 2005, Canadian respiratory journal.

Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.

G. Videtic, 2016, International journal of radiation oncology, biology, physics.

Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.

G. Barnett, C. Reddy, M. Vogelbaum, 2012, Lung cancer.

Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical Radiation Oncology.

Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion.

T. Zhuang, T. Djemil, G. Videtic, 2016, Clinical lung cancer.

Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.

T. Djemil, G. Videtic, K. Stephans, 2015, International journal of radiation oncology, biology, physics.

Stereotactic body radiation therapy-based treatment model for stage I medically inoperable small cell lung cancer.

C. Reddy, T. Djemil, G. Videtic, 2013, Practical radiation oncology.

POSTOPERATIVE ADJUVANT THERAPY IN NON-SMALL-CELL LUNG CANCER

K. Rosenzweig, B. Movsas, R. Decker, 2010 .

Continued C igarette S moking b y P atients R eceiving Concurrent C hemoradiotherap y f or L imited-Stage S mall-Cell Lung C ancer I s A ssociated W ith D ecreased S urvival

L. Stitt, E. Yu, G. Videtic, 2003 .

A Phase II Study of Perioperative Concurrent Chemotherapy, Gefitinib, and Hyperfractionated Radiation Followed by Maintenance Gefitinib in Locoregionally Advanced Esophagus and Gastroesophageal Junction Cancer

T. Rice, S. Murthy, L. Rybicki, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Synchronous non small cell lung cancer nodules treated with stereotactic body radiation therapy (SBRT).

T. Djemil, G. Videtic, Aryavarta M S Kumar, 2014, Journal of radiosurgery and SBRT.

Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.

G. Barnett, C. Reddy, M. Vogelbaum, 2009, International journal of radiation oncology, biology, physics.

Topology based radiomic feature derived from persistent homology predicts survival in non-small cell lung cancer patients treated with SBRT

G. Videtic, M. Kattan, R. Wadhwa, 2022, medRxiv.

The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.

C. Simone, S. Shirvani, B. Movsas, 2018, The Journal of thoracic and cardiovascular surgery.

Systematic errors in lung stereotactic body radiation therapy (SBRT): a caution on mixing and matching target delineation methods and planning CTs

P. Xia, T. Djemil, G. Videtic, 2015, Journal of Radiation Oncology.

Isolated Nodal Failure after Stereotactic Body Radiotherapy for Lung Cancer: The Role for Salvage Mediastinal Radiotherapy

G. Videtic, K. Stephans, N. Woody, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.

C. Reddy, K. Verdecchia, G. Videtic, 2019, Practical radiation oncology.

Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch.

A. Louie, S. Harden, G. Videtic, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Local Control With Single-Fraction Lung Stereotactic Body Radiotherapy is not influenced by Non-Small Cell Lung Cancer Histologic Subtype.

C. Reddy, G. Videtic, K. Stephans, 2022, Clinical lung cancer.

ACR Appropriateness Criteria s Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2015 .

ACR Appropriateness Criteria® Follow-up and Retreatment of Brain Metastases

M. McDermott, J. Bradley, L. Gaspar, 2012, American journal of clinical oncology.

Locally advanced non–small cell lung cancer: What is the optimal concurrent chemoradiation regimen?

G. Videtic, 2012, Cleveland Clinic Journal of Medicine.

Never too old ” : A single-institution experience of stereotactic body radiotherapy for patients 90 years and older with early stage lung cancer

C. Reddy, G. Videtic, K. Stephans, 2017 .

MA01.03 An Externally Validated Nomogram for Predicting Distant Metastasis After SBRT for Early Stage Non-Small Cell Lung Cancer

M. Kattan, J. Bradley, C. Robinson, 2018, Journal of Thoracic Oncology.

Dose differences in intensity‐modulated radiotherapy plans calculated with pencil beam and Monte Carlo for lung SBRT

Han Liu, P. Xia, T. Zhuang, 2015, Journal of applied clinical medical physics.

ACR Appropriateness Criteria s Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, B. Movsas, 2014 .

Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.

P. Mazzone, G. Videtic, Humberto K. Choi, 2015, Journal of radiosurgery and SBRT.

Radiation Recall Dermatitis after the Use of the Anorexiant Phentermine in a Patient with Breast Cancer

G. Videtic, R. Ash, 2006, The breast journal.

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC

V. Velcheti, G. Videtic, Christopher A. Lemmon, 2022, JTO clinical and research reports.

Approach to Oligometastatic Cancer in the Elderly Patient

G. Videtic, T. Smile, I. W. Winter, 2021, Current Oncology Reports.

The Initial Report of Local Control on RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients With Esophageal Cancer Treated Without Surgery

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

The Role of Radiation Therapy in Small Cell Lung Cancer

G. Videtic, 2013, Current Oncology Reports.

Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients with Locally Advanced Non-small Cell Lung Cancer - An Updated Analysis of RTOG 0214

H. Choy, M. Suntharalingam, L. Gaspar, 2012 .

ACR Appropriateness Criteria s Radiation Therapy for Small-Cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2014 .

Is extended volume external beam radiation therapy covering the anastomotic site beneficial in post-esophagectomy high risk patients?

L. Stitt, R. Malthaner, G. Rodrigues, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The development of stereotactic body radiotherapy (SBRT) for medically inoperable early stage non-small cell lung cancer: an international phenomenon

G. Videtic, 2012, Journal of Radiation Oncology.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Anurag K. Singh, P. Iyengar, H. Choy, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary chemoradiation as definitive treatment for unresectable cancer of the trachea.

G. Videtic, M. Vincent, C. Campbell, 2003, Canadian respiratory journal.

Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation.

L. Stitt, E. Yu, G. Videtic, 2004, Lung cancer.

Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung.

Ashutosh Kumar Singh, B. Slotman, A. Louie, 2022, Lung cancer.

OC-0136: Primary Study Endpoint Analysis of NRG Oncology/RTOG 0813 Trial of SBRT for centrally located NSCLC

Anurag K. Singh, P. Iyengar, H. Choy, 2016 .

MULTIPLE BRAIN METASTASES

J. Buatti, J. Bradley, I. Germano, 2014 .

American College of Radiology appropriateness criteria on multiple brain metastases.

M. McDermott, L. Gaspar, I. Germano, 2009, International journal of radiation oncology, biology, physics.

Induction chemotherapy inevitably leads to inferior outcome in combined modality treatment for unresectable stage III non-small cell lung cancer.

B. Jeremic, G. Videtic, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ACR Appropriateness Criteria s Early-Stage Non–Small–Cell Lung Cancer early-stage non–small–cell lung cancer, medical oper- ability, surgery, radiotherapy, adjuvant

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2014 .

Radiation Therapy Oncology Group (RTOG) Protocol 0915: A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer

Anurag K. Singh, H. Choy, G. Videtic, 2013 .

Categorizing segmentation quality using a quantitative quality assurance algorithm

Stewart Gaede, Glenn Bauman, George Rodrigues, 2011, Journal of medical imaging and radiation oncology.

Impact of intensity-modulated radiation therapy on outcomes for malignant pleural mesothelioma treated with trimodality therapy

C. Reddy, T. Rice, S. Murthy, 2014, Journal of Radiation Oncology.

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

P. Iyengar, A. Bezjak, J. Bradley, 2020, Radiotherapy and Oncology.

Esophageal adenocarcinoma: A dire need for early detection and treatment

S. Murthy, G. Videtic, S. Raja, 2022, Cleveland Clinic Journal of Medicine.

FOLLOW-UP AND RETREATMENT OF BRAIN METASTASES

J. Buatti, I. Germano, A. Vassil, 2014 .

30 Gy or 34 Gy? Comparing 2 single-fraction SBRT dose schedules for stage I medically inoperable non-small cell lung cancer.

T. Zhuang, C. Reddy, T. Djemil, 2014, International journal of radiation oncology, biology, physics.

Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: small-cell lung cancer (SCLC).

B. Jeremic, M. Martel, G. Videtic, 2008, International journal of radiation oncology, biology, physics.

Time Will Tell: Is 60 Gy in 3 Fractions the Optimal SBRT Schedule for Stage I Non-Small Cell Lung Cancer?

C. Reddy, T. Djemil, G. Videtic, 2014 .

A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer

C. Reddy, G. Videtic, L. Sorenson, 2012, Supportive Care in Cancer.

Early-Stage Non–Small-Cell Lung Cancer

G. Videtic, K. Stephans, S. Kilic, 2021, Essentials of Clinical Radiation Oncology.

A Histologic Basis for the Efficacy of SBRT to the lung

P. Xia, T. Zhuang, C. Reddy, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).

R. Arriagada, C. Faivre-Finn, S. Senan, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Initial reporting of NRG-LU001 (NCT02186847), randomized phase II trial of concurrent chemoradiotherapy (CRT) +/- metformin in locally advanced Non-Small Cell Lung Cancer (NSCLC).

J. Bradley, J. Erasmus, Richard J Lee, 2019, Journal of Clinical Oncology.

Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial

M. Suntharalingam, A. Raben, A. Dicker, 2017, JAMA oncology.

A Phase II Trial of Accelerated Multimodality Therapy for Locoregionally Advanced Cancer of the Esophagus and Gastroesophageal Junction: The Impact of Clinical Heterogeneity

T. Rice, S. Murthy, L. Rybicki, 2007, American journal of clinical oncology.

Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extracranial Irradiation for Extensive‐Disease Small Cell Lung Cancer (ED SCLC): NRG Oncology RTOG 0937

R. Hales, P. Iyengar, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

ACR Appropriateness Criteria® Radiation Therapy for Small-Cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2013, American journal of clinical oncology.

Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.

T. Rice, R. Tubbs, L. Rybicki, 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Long-term Follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer.

Joe Y. Chang, Anurag K. Singh, P. Iyengar, 2017, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiotherapy for the Management of Early-Stage Non-Small-Cell Lung Cancer: A Clinical Overview.

G. Videtic, D. Buchberger, 2023, JCO oncology practice.

ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2009, Journal of the American College of Radiology : JACR.

DEFINITIVE MANAGEMENT OF INOPERABLE NON–SMALL CELL LUNG CANCER

T. Mekhail, G. Videtic, D. Adelstein, 2008 .

Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial.

H. Choy, M. Suntharalingam, L. Gaspar, 2019, JAMA oncology.

Fatal cerebral air embolus complicating multimodality treatment of esophageal cancer.

T. Rice, S. Murthy, E. Manno, 2011, The Annals of thoracic surgery.

Oligometastatic Non-Small-Cell Lung Cancer.

D. Palma, G. Videtic, 2015, International journal of radiation oncology, biology, physics.

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.

R. Hales, M. Mehta, C. Simone, 2017, International journal of radiation oncology, biology, physics.

The Role of Radiotherapy in Small Cell Lung Cancer: a Revisit

G. Videtic, 2015, Current Oncology Reports.

Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.

Edward Clouser, C. Reddy, T. Djemil, 2010, International journal of radiation oncology, biology, physics.

The Role of Stereotactic Body Radiotherapy in the Management of Non-Small Cell Lung Cancer: An Emerging Standard for the Medically Inoperable Patient?

G. Videtic, K. Stephans, 2010, Current Oncology Reports.

A Comparison of Two Stereotactic Body Radiation Fractionation Schedules for Medically Inoperable Stage I Non-small Cell Lung Cancer: The Cleveland Clinic Experience

Tarek Mekhail, C. Reddy, P. Mazzone, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients

C. Reddy, P. Mazzone, T. Djemil, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases

C. Shah, G. Videtic, Kailin Yang, 2023, American journal of clinical oncology.

ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2015, American journal of clinical oncology.

INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER

K. Rosenzweig, I. Chetty, B. Loo, 2013 .

The efficacy of external beam radiotherapy and stereotactic body radiotherapy for painful spinal metastases from renal cell carcinoma.

C. Reddy, T. Djemil, G. Videtic, 2012, Practical radiation oncology.

Improving the consistency in cervical esophageal target volume definition by special training.

Jake Van Dyk, James Brierley, Edward Yu, 2002, International journal of radiation oncology, biology, physics.

Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

K. Rosenzweig, W. Curran, H. Choy, 2015, Practical radiation oncology.

ACR Appropriateness Criteria® Early-Stage Non–Small–Cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2014, American journal of clinical oncology.

ACR Appropriateness Criteria s Early-Stage Non-Small-Cell Lung Cancer

K. Rosenzweig, I. Chetty, B. Loo, 2014 .

ACR Appropriateness Criteria® Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer

Joe Y. Chang, K. Rosenzweig, B. Movsas, 2011, American journal of clinical oncology.

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

Ashutosh Kumar Singh, S. Yendamuri, G. Videtic, 2022, Cancers.

Optimal imaging surveillance after stereotactic ablative radiation therapy for early-stage non-small cell lung cancer: Findings of an International Delphi Consensus Study.

Timothy K. Nguyen, R. Timmerman, B. Loo, 2018, Practical radiation oncology.

Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement

P. Iyengar, A. Bezjak, J. Bradley, 2020, International Journal of Radiation Oncology*Biology*Physics.

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer

D. Gomez, D. de Ruysscher, A. Louie, 2021, Advances in radiation oncology.

Does motion management technique for lung SBRT influence local control? A single institutional experience comparing abdominal compression to breath-hold technique.

G. Videtic, K. Stephans, N. Woody, 2020, Practical radiation oncology.

Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.

T. Zhuang, K. Verdecchia, G. Videtic, 2020, International journal of radiation oncology, biology, physics.

Investigation of brachial plexus dose that exceeds RTOG constraints for apical lung tumors treated with four- or five-fraction stereotactic body radiation therapy.

T. Zhuang, C. Reddy, K. Verdecchia, 2018, Journal of radiosurgery and SBRT.

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline.

C. Simone, R. Timmerman, S. Shirvani, 2017, Practical radiation oncology.

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy

P. Xia, T. Zhuang, G. Videtic, 2021, Cureus.

Outpatient Anesthesia Facilitates Stereotactic Body Radiation Therapy for Early Stage Lung Cancer Patients With Advanced Cognitive Impairments

C. Reddy, G. Videtic, K. Stephans, 2019, Advances in radiation oncology.

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical Trial.

J. Bradley, J. Erasmus, R. Mcgarry, 2021, JAMA oncology.

Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis

P. Fu, G. Videtic, F. Fakhrejahani, 2019, Journal of Radiation Oncology.

Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non–Small Cell Lung Cancer: NRG Oncology RTOG 0839

B. Loo, M. Diehn, J. Bradley, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases.

T. Rice, T. Mekhail, G. Videtic, 2004, International journal of radiation oncology, biology, physics.

Brain metastases in small cell lung cancer.

G. Videtic, J. Suh, Aimee L Quan, 2004, Oncology.

γ-Knife Radiosurgery for Brainstem Lesions: The Wayne State University Experience

L. Zamorano, F. Diaz, L. Gaspar, 1999 .

PRE-IRRADIATION EVALUATION AND MANAGEMENT OF BRAIN METASTASES

J. Buatti, J. Bradley, I. Germano, 2014 .

Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline

K. Rosenzweig, A. Bezjak, J. Bradley, 2011, Practical radiation oncology.

Is Extended Volume of External Beam Irradiation Beneficial in Post-esophagectomy High Risk Patients Receiving Combined Chemoradiation Therapy?

L. Stitt, R. Malthaner, E. Yu, 2001 .

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

C. Reddy, S. Senan, F. Lagerwaard, 2015, International journal of radiation oncology, biology, physics.

A practical guide to the management of dysphagia in patients with metastatic esophageal cancer

G. Videtic, D. Sohal, A. Bhatt, 2018 .

Inter-breath-hold motion in gated cone-beam CT introducing uncertainties in image-guided radiotherapy for breath-hold treatment

P. Xia, T. Zhuang, T. Djemil, 2014, Journal of Radiation Oncology.

Smoking Cessation, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

J. Prochaska, B. Hitsman, P. Shields, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2014, Oncology.

Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery.

P. Mazzone, G. Videtic, K. McCarthy, 2015, The Journal of thoracic and cardiovascular surgery.

Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial.

Jeffrey D Bradley, Fenghai Duan, Janet S. Reddin, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

C. Simone, J. Bradley, A. Louie, 2023, Practical radiation oncology.

Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer

H. Choy, R. Komaki, K. Bae, 2009 .

Report from the International Atomic Energy Agency (IAEA) consultants' meeting on elective nodal irradiation in lung cancer: non-small-Cell lung cancer (NSCLC).

B. Jeremic, M. Martel, G. Videtic, 2008, International journal of radiation oncology, biology, physics.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials

M. Suntharalingam, A. Raben, C. Hallemeier, 2023, JAMA network open.

A phase I safety and feasibility study of neoadjuvant chemoradiation plus pembrolizumab followed by consolidation pembrolizumab in resectable stage IIIA non-small cell lung cancer.

V. Velcheti, S. Murthy, G. Videtic, 2020 .

Oncology scan--defining dose, fractionation, and target volume in small cell lung cancer.

G. Videtic, 2014, International journal of radiation oncology, biology, physics.

B. Jeremic, G. Videtic, N. Cihoric, 2018, Front. Oncol..

Combined modality therapy in Stage IIIA non–small cell lung cancer: clarity or confusion despite the highest level of evidence?

B. Jeremic, G. Videtic, N. Cihoric, 2017, Journal of radiation research.

Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213.

Benjamin Movsas, Hak Choy, Kyounghwa Bae, 2011, Clinical lung cancer.

Intra‐ and inter‐fractional liver and lung tumor motions treated with SBRT under active breathing control

P. Xia, T. Djemil, G. Videtic, 2017, Journal of applied clinical medical physics.

Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.

D. Ettinger, W. Curran, H. Choy, 2012, International journal of radiation oncology, biology, physics.

NRG-RTOG 1106/ACRIN 6697: A phase IIR trial of standard versus adaptive (mid-treatment PET-based) chemoradiotherapy for stage III NSCLC—Results and comparison to NRG-RTOG 0617 (non-personalized RT dose escalation).

B. Loo, J. Bradley, J. Hayman, 2021 .

Incidental Mediastinal Nodal Radiation During Stereotactic Radiation for Lung Tumors: Implications for High-dose Treatment of Locally Advanced Disease

T. Djemil, G. Videtic, K. Stephans, 2012 .

The Role of Stereotactic Radiotherapy in the Treatment of Oligometastases

G. Videtic, 2014, Current Oncology Reports.

The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.

M. Suntharalingam, A. Raben, A. Dicker, 2014 .

Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients

J. Galvin, H. Choy, R. Timmerman, 2007 .

Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review.

B. Jeremic, G. Videtic, 2011, International journal of radiation oncology, biology, physics.

Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.

Ping Xia, Yongbok Kim, P. Xia, 2012, International journal of radiation oncology, biology, physics.

Re-irradiation in lung cancer

A. Vassil, G. Videtic, K. Stephans, 2015, Journal of Radiation Oncology.

A Comparison of Stereotactic Body Radiation (SBRT) Fractionation Schedules for Stage I Non-small Cell Lung Cancer (NSCLC): The Cleveland Clinic Experience

C. Reddy, T. Djemil, G. Videtic, 2008 .

Early-Stage Non–Small-Cell Lung Cancer

G. Videtic, K. Stephans, S. Kilic, 2021, Essentials of Clinical Radiation Oncology.

Surgery for Stage IIIA Non-Small-cell Lung Cancer: Lack of Predictive and Prognostic Factors Identifying Any Subgroup of Patients Benefiting From It.

B. Jeremic, G. Videtic, N. Cihoric, 2016, Clinical lung cancer.

No Clinically Significant Changes in Pulmonary Function Following Stereotactic Body Radiation Therapy (SBRT) Among Medically Inoperable Patients With Early Stage Peripheral Non-small Cell Lung Cancer: An Analysis of RTOG 0236

R. Timmerman, A. Bezjak, J. Bradley, 2012 .

Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction

T. Rice, S. Murthy, L. Rybicki, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chest Wall Toxicity from Lung Stereotactic Body Radiotherapy (SBRT): A Dosimetric Analysis using Several Fractionation Schemes

P. Xia, T. Djemil, G. Videtic, 2010 .

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

C. Reddy, T. Djemil, G. Videtic, 2010, International journal of radiation oncology, biology, physics.

Lymphopenia as a predictor of survival in chemoradiation (CRT)-treated stage III non-small cell lung cancer (NSCLC).

G. Videtic, F. Fakhrejahani, K. Redmond, 2015 .

Gefitinib in definitive management of esophageal or gastroesophageal junction cancer: a retrospective analysis of two clinical trials.

T. Rice, S. Murthy, R. Tubbs, 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Stereotactic Body Radiation Therapy (SBRT) for Primary Lung Cancer

G. Videtic, 2019, Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.

J. Hearn, T. Djemil, G. Videtic, 2014, International journal of radiation oncology, biology, physics.

ASTRO's Advances in Radiation Oncology: Success to date and future plans

Sharad Goyal, Charles Mayo, C. Mayo, 2017, Advances in radiation oncology.

OA12.03 Initial Reporting of NRG-LU001, Randomized Phase II Trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC

J. Bradley, J. Erasmus, Richard J Lee, 2019, Journal of Thoracic Oncology.

Shifting from hypofractionated to "conventionally" fractionated thoracic radiotherapy: a single institution's 10-year experience in the management of limited-stage small-cell lung cancer using concurrent chemoradiation.

L. Stitt, E. Yu, G. Videtic, 2003, International journal of radiation oncology, biology, physics.

Importance of residual primary cancer after induction therapy for esophageal adenocarcinoma.

John Ehrlinger, Eugene H Blackstone, J. Goldblum, 2016, The Journal of thoracic and cardiovascular surgery.

NRG Oncology/RTOG 0937: Randomized Phase 2 Study Comparing Prophylactic Cranial Irradiation (PCI) Alone to PCI and Consolidative Extracranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)

R. Hales, P. Iyengar, J. Bradley, 2016 .

Managing Local Recurrence After Primary Resection of Non-Small Cell Lung Cancer: The Role for Salvage Stereotactic Body Radiation Therapy

A. Vassil, G. Videtic, K. Stephans, 2016 .

Persistent homology derived radiomic feature predicts survival in non-small cell lung cancer patients treated with SBRT

Raoul R. Wadhwa, M. Kattan, G. Videtic, 2022 .

ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2009, Journal of the American College of Radiology : JACR.

ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent.

Joe Y. Chang, K. Rosenzweig, I. Chetty, 2014, Oncology.

Choice of Radiotherapy Planning Modality Influences Toxicity in the Treatment of Locally Advanced Esophageal Cancer

Jonathan S. Adelstein, C. Reddy, T. Rice, 2008, Journal of gastrointestinal cancer.

Is adaptive planning necessary for patients with large tumor position displacements observed on daily image guidance during lung SBRT?

P. Xia, G. Videtic, Saeed Ahmed, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

SU-F-J-141: Real-Time Position Management (RPM) System as a Valuable Tool to Predict Tumor Position Deviation in SBRT Lung and Liver Patients with Breath Hold Using Active Breathing Coordinator (ABC).

P. Xia, T. Zhuang, G. Videtic, 2016, Medical physics.

Toxicities in a phase II study of accelerated high dose thoracic radiation therapy (TRT) with concurrent chemotherapy for limited small cell lung cancer (LSCLC) (RTOG 0239)

D. Ettinger, H. Choy, J. Bradley, 2007 .

Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohort.

T. Rice, S. Murthy, T. Mekhail, 2008, International Journal of Radiation Oncology, Biology, Physics.

Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.

C. Reddy, G. Videtic, K. Stephans, 2021, International journal of radiation oncology, biology, physics.

Local Treatments of Oligometastatic and Oligoprogressive NSCLC Should Become the Standard of Care.

G. Videtic, 2023, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Treatment of Peripheral Non–Small Cell Lung Carcinoma with Stereotactic Body Radiation Therapy

J. Bradley, G. Videtic, M. Roach, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Hyperbaric oxygen corrects sacral plexopathy due to osteoradionecrosis appearing 15 years after pelvic irradiation.

G. Videtic, V. Venkatesan, Gregory M Videtic, 1999, Clinical oncology (Royal College of Radiologists (Great Britain)).

INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER

K. Rosenzweig, I. Chetty, B. Loo, 2013 .

Oligometastatic Non-Small-Cell Lung Cancer.

D. Palma, G. Videtic, 2015, International journal of radiation oncology, biology, physics.

Radiation therapy in small cell lung cancer.

I. Chetty, L. Kestin, C. Perez, 1978, Seminars in Oncology.

Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.

C. Reddy, T. Djemil, G. Videtic, 2010, International journal of radiation oncology, biology, physics.

Never too old: A single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer.

C. Reddy, G. Videtic, K. Stephans, 2017, Practical radiation oncology.

Stereotactic body radiation therapy and lung cancer

G. Videtic, 2013 .

Management of Brain Metastases in Patients With SCLC: Defining the Role for Stereotactic Radiosurgery

G. Barnett, C. Reddy, R. Kotecha, 2015 .

H. Choy, R. Komaki, K. Bae, 2011, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria: single brain metastasis.

M. McDermott, L. Gaspar, I. Germano, 2010, Current problems in cancer.

Stage III Non–Small-Cell Lung Cancer

G. Videtic, M. Ward, A. Juloori, 2021, Essentials of Clinical Radiation Oncology.

Categorizing segmentation quality using a quantitative quality assurance algorithm

J. Battista, G. Bauman, A. Louie, 2012, Journal of medical imaging and radiation oncology.

A phase II trial of perioperative concurrent chemoradiotherapy (CCRT) and gefitinib (G) in locally advanced esophagus (E) and gastroesophageal junction (GEJ) cancer

T. Rice, S. Murthy, L. Rybicki, 2008 .

The Treatment of Patients with Early-Stage Non-Small Cell Lung Cancer Who Are Not Candidates or Decline Surgical Resection: The Role of Radiation and Image-Guided Thermal Ablation

G. Videtic, D. Buchberger, Rishabh Khurana, 2024, Journal of Clinical Medicine.